Research Articles | Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort Aug 2020 Pediatric Blood & Cancer Aplastic Anemia, Pediatric
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium Aug 2020 Pediatric Blood & Cancer Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study Dec 2023 Orphanet Journal of Rare Diseases Aplastic Anemia
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Oct 2023 Oncologist Myelodysplastic Syndromes (MDS)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Aug 2020 Nature Medicine Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Mar 2019 National Cancer Institute Myelodysplastic Syndromes (MDS)
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia Jun 2023 Molecular Medicine Aplastic Anemia
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy Jan 2024 Mediterranean Journal of Hematology and Infectious Diseases Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 Apr 2020 Leukemia Research Reports Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS) Mar 2019 Leukemia Research Myelodysplastic Syndromes (MDS)